Presentation | July 11, 2024

Integrated Biologics CDMO Services

Source: Mycenax
Scientist research laboratory pipette GettyImages-487041629

Mycenax, a Contract Development and Manufacturing Organization (CDMO), offers comprehensive biopharmaceutical services and solutions across a global market. Founded in 2019 with a core competency in biosimilars and novel biopharmaceuticals, Mycenax has undertaken a strategic shift towards developing advanced technology platforms and expanding its GMP-compliant manufacturing facilities. This expansion strengthens Mycenax's ability to cater to diverse client needs by providing a comprehensive and streamlined CDMO service model.

access the Presentation!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Mycenax